Does science-based patenting make inventions more likely to be traded?
Core argument: Patents citing scientific papers are 16–23% more likely to be traded, which the authors take as an indication of higher quality innovation.
The reallocation of federal R&D spending from defense to fields like computer science, oceanography, and biology has led to significant shifts in research output and patent value. Post-USSR collapse, federal funding for Space and Defense fell by nearly 40% between 1986-1992, while Medical and Energy funding doubled, resulting in more science-based patents. Patents citing scientific papers are 16-23% more likely to be traded, indicating higher quality innovation. The share of patents citing science rose from 4% to 28% between 1980-2015. Smaller firms benefit more from science-based patents, with a fourfold larger impact on market for technology (MFT) compared to larger firms. A standard deviation increase in science-based patents correlates with a 6.5% rise in reassigned patents, underscoring the economic value of science-driven innovation.





Ed Comment:“My thinking isn't clear on this but my sense from being on the waters board is that academic research is woefully unproductive relative to commercial research. Yet academies siphone off an enormous amount of talent. So the gov funding more academic research may make the academics more productive in response to the funding than they otherwise would be. But in general, gov funding of academic research makes talented people less productivity because it makes the academies larger than they otherwise would be. Is this a variation of the Simpson paradox?”